IF
HRTX icon

Ironwood Financial’s Heron Therapeutics HRTX Stock Holding History

Ironwood Financial’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,927
Closed -$31K – 295
2021
Q3 		$31K Hold
2,927
– – 0.01% 236
2021
Q2 		$45K Hold
2,927
– – 0.01% 196
2021
Q1 		$47K Hold
2,927
– – 0.02% 179
2020
Q4 		$62K Hold
2,927
– – 0.02% 157
2020
Q3 		$43K Hold
2,927
– – 0.02% 126
2020
Q2 		$43K Hold
2,927
– – 0.02% 116
2020
Q1 		$34K Buy
2,927
+239
+9% +$4.49K 0.02% 109
2019
Q4 		$63K Hold
2,688
– – 0.03% 95
2019
Q3 		$50K Buy
2,688
+30
+1% +$552 0.02% 111
2019
Q2 		$49K Hold
2,658
– – 0.02% 113
2019
Q1 		$65K Hold
2,658
– – 0.03% 94
2018
Q4 		$69K Buy
2,658
+225
+9% +$6.19K 0.04% 85
2018
Q3 		$77K Hold
2,433
– – 0.04% 85
2018
Q2 		$95K Buy
2,433
+330
+16% +$10.5K 0.06% 66
2018
Q1 		$58K Buy
2,103
+408
+24% +$9.26K 0.06% 61
2017
Q4 		$31K Hold
1,695
– – 0.02% 110
2017
Q3 		$27K Hold
1,695
– – 0.02% 121
2017
Q2 		$23K Sell
1,695
-6,105
-78% -$88.4K 0.01% 124
2017
Q1 		$117K Hold
7,800
– – 0.08% 57
2016
Q4 		$102K Buy
+7,800
New +$122K 0.07% 59

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ironwood Financial's HRTX Position: Q4 2021 in Review

Ironwood Financial sold out of Heron Therapeutics (HRTX) in Q4 2021, closing a stake of 2,927 shares — an estimated $31K sold.

Ironwood Financial first reported a position in HRTX in Q4 2016 and held it in 20 quarters. The position peaked at $117K in Q1 2017. 200 funds tracked by Wall St. Rank hold HRTX as of Q4 2021.

  • Ironwood Financial reported no remaining Heron Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Ironwood Financial sold 2,927 Heron Therapeutics shares in Q4 2021, an estimated $31K.
  • Ironwood Financial first reported a position in Heron Therapeutics in Q4 2016 and held it in 20 quarters.
  • Ironwood Financial's Heron Therapeutics position peaked at $117K in Q1 2017.
  • 200 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.